Private biotech company focused on developing modulators of intracellular protein-protein interactions employing a proprietary technology platform. The most advanced of these first-in-class therapeutics, an oral modulator of dysregulated transcription, is currently in preclinical development.

Location

Einsiedlerstrasse 34, 8820 Wädenswil, Schweiz

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2013

  • Number of employees in Switzerland

    1-9

Key business